ENTITY
Novo Nordisk

Novo Nordisk (NOVOB DC)

75
Analysis
Health Care • Denmark
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
more
bearish•Cross Asset Strategy
•24 Sep 2025 15:23•Syndicated

CX Daily: Lean Times Ahead for Producers of Weight-Loss Drugs

TOP STORIES In Depth: Lean Times Ahead for Producers of Weight-Loss Drugs A new class of drugs has transformed weight loss worldwide, for those...

Logo
190 Views
Share
•27 Feb 2024 21:09•Syndicated

Europe's Magnificent Eleven

The GRANOLAS Dubbed the “Granolas” by Goldman Sachs in 2020, this basket was chosen because it echoed themes present amongst the Mag 7 (back then...

Logo
348 Views
Share
x